gimli
CONCORDBIO stock analysis context
CONCORD BIOTECH Stock Context for AI Screening
CONCORD BIOTECH LIMITED is a small-cap stock in Healthcare. This page summarizes key screening signals for CONCORD BIOTECH, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about CONCORDBIOPrice
₹1,153.30
1M return
+9.61%
3M return
+5.05%
Market cap
₹12,065.39 cr
PE
38.78
ROE
+18.64%
RSI
54.74
Turnover
₹23.03 cr
Why it can matter in screens
- Momentum: CONCORDBIO is above 50DMA; RSI is 54.74.
- Returns: 1M +9.61%, 3M +5.05%, 6M -19.22%.
- Liquidity: latest turnover is ₹23.03 cr.
- Valuation: PE 38.78, PB n/a, ROE +18.64%, ROCE +24.73%.
- Growth: 3Y sales CAGR +18.53%, 3Y profit CAGR +28.55%.
Try these prompts
- Analyze CONCORD BIOTECH with valuation, momentum and industry peers
- Compare CONCORDBIO with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare CONCORDBIO with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.